Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation

Clinical trial NCT06668324 · COMPLETED

Trial details

NCT number: NCT06668324
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2024-11-15
Primary completion: 2025-09-05
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.